Skip to main content
  • 19 Accesses

Abstract

In the limited time that molecular cloning techniques have been successfully applied to neurotransmitter receptors, we have learned of strong sequence homologies among one group of receptors, the G protein-coupled receptors, that unite these proteins into one structural family [1]. Members of this family include the muscarinic cholinoceptors, alpha- and beta-adrenoceptors, opsin and the Substance K receptor [1, 2]. All members of this family are single subunit proteins containing seven membrane-spanning domains with interconnecting extracellular and cytoplasmic sequences. The transmembrane domains exhibit strong sequence homologies among the family members, while the interconnecting water soluble domains are less well conserved. Recently, the 5-HT1C receptor became the first serotonergic member of this family of cloned G-protein-coupled receptors, and so became the first 5-hydroxytryptamine (5-HT) receptor subtype to be understood at the amino acid sequence level [3, 4]. The strategy used to clone the 5-HT1C receptor is a powerful new approach to molecular cloning, which will be broadly applicable to many receptor and ion channel proteins. The basics of this strategy will be reviewed in this chapter, along with information it has provided on the structure of the 5-HT1C receptor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. Dohlman HG, Caron MG, Lefkowitz RJ (1987): A family of receptors coupled to guanine nucleotide regulatory proteins, Biochemistry26: 2657–2664.

    Article  CAS  PubMed  Google Scholar 

  2. Lester HA (1988): Heterologous expression of excitability proteins: route to more specific drugs? Science241: 1057–1063.

    Article  CAS  PubMed  Google Scholar 

  3. Lübbert H, Hoffman BJ, Snutch TP, van Dyke T, Levine AJ, Hartig PR, Lester HA, Davidson N (1987): cDNA cloning of a serotonin 5-HT1c receptor by using electrophysiological assays of mRNA-injected Xenopus oocytes. Proc Natl Acad Sci USA 84:4332–4336.

    Article  PubMed  Google Scholar 

  4. Julius D, MacDermott AB, Axel R, Jessell TM (1988): Molecular characterization of a functional cDNA encoding the serotonin 5-HT1c receptor. Science241: 558–564.

    Article  CAS  PubMed  Google Scholar 

  5. Gundersen CB, Miledi R, Parker I (1983): Serotonin receptors induced by exogenous messenger RNA in Xenopus oocytes. Proc Royal Soc LondonB219: 103–109.

    Article  Google Scholar 

  6. Dascal N, Ifune C, Hopkins R, Snutch TP, Lübbert H, Davidson N, Simon MI, Lester HA (1986): Involvement of a GTP-binding protein in mediation of serotonin and acetylcholine responses in Xenopus oocytes injected with rat brain messenger RNA Mol Brain Res1: 201–209.

    Article  CAS  Google Scholar 

  7. Lübbert H, Snutch TP, Dascal N, Lester HA, Davidson N (1987): Rat brain 5-HT1c receptors are encoded by a 5–6 kbase mRNA size class and are functionally expressed in injected Xenopus oocytes.J Neurosci7: 1159–1165.

    Google Scholar 

  8. Yagaloff KA, Lozano G, van Dyke T, Levine AJ, Hartig PR (1986): Serotonin 5-HT1c receptors are expressed at high density on choroid plexus tumors from transgenic mice. Brain Res385: 389–394.

    Article  CAS  PubMed  Google Scholar 

  9. Hoffman BJ (1988): Molecular pharmacology of serotonin receptors: radioligand development, mechanisms of signal transduction, and cloning of a receptor gene. Doctoral thesis, Johns Hopkins University.

    Google Scholar 

  10. Sutcliffe JG (1988): mRNA in the mammalian central nervous system. Ann Rev Neurosci 11:157–198.

    Article  CAS  PubMed  Google Scholar 

  11. Dixon RAF, Sigal IS, Rands E, Register RB, Candelore MR, Blake AD, Strader CD (1987): Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like core, Nature326: 73–77.

    Article  CAS  PubMed  Google Scholar 

  12. Dixon RAF, Sigal IS, Candelore MR, Register RB, Scattergood W, Rands E, Strader CD (1987): Structural features required for ligand binding to the beta-adrenergic receptor, EMBO Journal6: 3269–3275.

    CAS  PubMed  Google Scholar 

  13. Kobilka BK, Kobilka TS, Daniel K, Regan JW, Caron MG, Lefkowitz RJ (1988): Chimeric alpha2-, beta2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity, Science240: 1310–1316.

    Article  CAS  PubMed  Google Scholar 

  14. Strader CD, Sigal IS, Register RB, Candelore MR, Rands E, Dixon RAF (1987): Identification of residues required for ligand binding to the beta-adrenergic receptor, Proc Natl Acad Sci USA84: 4384–4388.

    Article  CAS  PubMed  Google Scholar 

  15. Hoyer D (1988): Moleuclar pharmacology and biology of 5-HT1c receptors, Trends Pharm Sci9: 89–94.

    Article  CAS  PubMed  Google Scholar 

  16. Peroutka SJ (1988): 5-Hydroxytryptamine Receptor Subtypes, Ann Rev Neurosci 11: 45–60.

    Article  CAS  PubMed  Google Scholar 

  17. Hartig PR (1989): Molecular biology of 5-HT receptors. Trends Pharm Sci10: 64–69.

    Article  CAS  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Hartig, P.R. (1990). Cloning of the choroid plexus 5-HT1C receptor. In: Saxena, P.R., Wallis, D.I., Wouters, W., Bevan, P. (eds) Cardiovascular Pharmacology of 5-Hydroxytryptamine. Developments in CardioCardiovascular Pharmacology of 5-Hydroxytryptamine, vol 106. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0479-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0479-8_3

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6701-0

  • Online ISBN: 978-94-009-0479-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics